EMD

8.82%

3.7¢

EMYRIA LIMITED

Market Cap $17.04M Add to my watchlist

Healthcare Biotechnology

Emyria Limited is an Australia-based early-stage drug development company. The Company is... Emyria Limited is an Australia-based early-stage drug development company. The Company is focused on delivering and developing treatments for mental health and select neurological conditions, guided by real-world data collected with patients across its wholly owned clinical service subsidiaries. Its pipeline comprises medication-assisted treatment programs and biopharmaceuticals, specifically methylenedioxy-methylamphetamine (MDMA) analogues and Ultra-Pure cannabidiol (CBD) capsules. Its Emyria Healthcare provides evidence-based treatment for patients not finding relief from conventional care, while also helping evaluate emerging new therapies like MDMA-assisted therapy for PTSD. Its Emyria Data is a robust and ethically sourced real-world data gathered with patients and used to improve its therapy and drug development programs. Its Emyria’s Pipeline includes new psychedelic-assisted therapies and drug treatments for mental health and select neurological diseases.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

Latest Threads

Tag

Subject

EMD

Ann: Leadership Updates

19:29

1.3K

19:29

Last post FiSaver

1.3K

EMD

Emyria Research Report

21/01/25

6.6K

21/01/25

Last post rasberry

6.6K

EMD

Psychedelics News

24/12/24

3.6K

24/12/24

Last post Lollies

3.6K

EMD

Ann: Section 708A(5)(e) Notice

12/12/24

225

12/12/24

Last post

ASX News

225

EMD

Ann: Application for quotation of securities - EMD

12/12/24

226

12/12/24

Last post

ASX News

226

EMD

Ann: Emyria Secures $2.525M in Strongly Supported Placement

30/11/24

2.4K

30/11/24

Last post CRUSTY1981

2.4K

EMD

Ann: Investor Update - November 2024

27/11/24

1.3K

27/11/24

Last post CRUSTY1981

1.3K

EMD

Ann: Proposed issue of securities - EMD

27/11/24

302

27/11/24

Last post

ASX News

302

See All Discussions

Timeline

Leadership Updates
22 Jan 09:20	Share

Section 708A(5)(e) Notice
12 Dec 12:53	Share

Application for quotation of securities - EMD
12 Dec 12:49	Share

Proposed issue of securities - EMD
27 Nov 10:09	Share

Emyria Secures $2.525M in Strongly Supported Placement
27 Nov 10:08	Share

Investor Update - November 2024
25 Nov 09:58	Share

Trading Halt
25 Nov 09:40	Share

Notification of cessation of securities - EMD
15 Nov 18:32	Share

Response to ASX Price Query
12 Nov 15:19	Share

Results of Annual General Meeting
12 Nov 14:40	Share

Proposed issue of securities - EMD
31 Oct 10:44	Share

Emyria & UWA Partner to License Novel Serotonin Therapies
31 Oct 09:58	Share

September 2024 Quarterly Activities Report and Appendix 4C
30 Oct 10:38	Share

Emyria Gains Ethics Endorsement for Psilocybin Program
28 Oct 10:00	Share

Letter to Shareholders - Notice of Annual General Meeting
11 Oct 15:53	Share

Notice of Annual General Meeting/Proxy Form
11 Oct 15:52	Share

Appendix 4G and Corporate Governance Statement
11 Oct 15:50	Share

Annual Report
11 Oct 15:50	Share

Change of Director's Interest Notice x 2
23 Sep 12:38	Share

Section 708A(5)(e) Notice
20 Sep 17:26	Share

Notification regarding unquoted securities - EMD
20 Sep 17:19	Share

Application for quotation of securities - EMD
20 Sep 17:15	Share

2024 Annual General Meeting - Key Dates
16 Sep 17:27	Share

Hidden Gems Webinar Presentation
06 Sep 08:58	Share

Emyria Shares Interim Success in PTSD Treatment Program
02 Sep 09:50	Share

Appendix 4E & Annual Report for the Year Ended 30 June 2024
30 Aug 14:35	Share

Results of Meeting
21 Aug 16:43	Share

June 2024 Quarterly Activities Report and Appendix 4C
30 Jul 09:06	Share

Letter to Shareholders - Notice of General Meeting
19 Jul 11:08	Share

Notice of General Meeting/Proxy Form
19 Jul 11:08	Share

View More

(20min delay)
Last 3.7¢		Change 0.003(8.82%)		Mkt cap ! $17.04M

Open	High	Low	Value	Volume
3.5¢	3.7¢	3.4¢	$1.545K	44.53K

Buyers (Bids)

No.	Vol.	Price($)
1	19150	3.4¢

Sellers (Offers)

Price($)	Vol.	No.
3.7¢	273547	4

View Market Depth

No.	Vol.	Price($)
1	19150	0.034
2	45456	0.033
1	30000	0.032
3	88158	0.031
7	484383	0.030

Price($)	Vol.	No.
0.037	273547	4
0.038	52594	1
0.040	47083	1
0.041	30000	1
0.043	185349	1

Last trade - 16.10pm 23/01/2025 (20 minute delay)


Last 3.4¢		Change 0.003 ( 5.56 %)
Open	High	Low	Volume
3.7¢	3.7¢	3.4¢	18129
Last updated 14.01pm 23/01/2025 ?

EMD (ASX) Chart

EMYRIA LIMITED

Latest Threads

Timeline

Featured News

Latest Videos

Emyria (ASX:EMD) recruits first patient in MDMA-assisted therapy trial for PTSD

10 Jul 2023 12:47 (AEST)

Emyria (ASX:EMD) pockets more than $2m R&D tax refund

12 Jan 2023 10:34 (AEDT)

Latest Articles

Emyria to plug $2.5M into depression treatment program at Empax Centre

Emyria Ltd has rolled out a Placement to raise more than $2M to expand mental health treatments at its Leederville centre

Emyria, UWA seek commercialisation of compounds to treat PTSD and Parkinson's

Emyria and the University of Western Australia have formed a partnership to secure global rights to a library of patented compounds.

Emyria jumps 10% on 'interim' success treating PTSD patients with MDMA

Shares in MDMA psychotherapy player Emyria (ASX:EMD) jumped 9.4% to 3.5cps on Monday following reports of 'interim' success treating patients with PTSD.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News